Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population
ContextWolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is characterized by central diabetes insipidus, juvenile-onset diabetes mellitus (DM), optic atrophy (OA), and deafness. The natural history of WS is variable, even wi...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1525846/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832582880178470912 |
---|---|
author | Inbal Halabi Inbal Halabi Yardena Tenenbaum-Rakover Yardena Tenenbaum-Rakover Lena Sagi-Dain Lena Sagi-Dain Lena Sagi-Dain Ilana Koren Ilana Koren Ilana Koren |
author_facet | Inbal Halabi Inbal Halabi Yardena Tenenbaum-Rakover Yardena Tenenbaum-Rakover Lena Sagi-Dain Lena Sagi-Dain Lena Sagi-Dain Ilana Koren Ilana Koren Ilana Koren |
author_sort | Inbal Halabi |
collection | DOAJ |
description | ContextWolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is characterized by central diabetes insipidus, juvenile-onset diabetes mellitus (DM), optic atrophy (OA), and deafness. The natural history of WS is variable, even within the same family and with the same variant.ObjectiveTo report the phenotypes of five patients of Druze origin, all carrying the same autosomal recessive pathogenic variant in the WFS1 gene.Patients & methodsFive patients belonging to three core families were enrolled. Clinical, biochemical, and genetic data were retrieved retrospectively from their medical files.ResultsAll five patients carried the same previously reported homozygous WFS1 pathogenic variant: c.2649del, p.Phe884fs. In all patients, the first presentation was DM at a mean age of 5.2 years (range 4–7), diagnosed initially as type 1 DM with negative anti-pancreatic autoantibodies, and all were treated with insulin by either pump or multiple injections. All five patients had OA that appeared at a mean age of 12.3 years (range 4–30). Three had hearing loss and neurological involvement, and none had diabetes insipidus. One patient was treated with a glucagon-like peptide 1 receptor agonist with a good response.ConclusionsThis is the first report of a founder pathogenic variant in the WFS1 gene in the Druze population in Israel. Our findings imply that molecular analysis is warranted in children presenting with DM and negative pancreatic antibodies. The identified variant should be considered for genetic testing in individuals of Druze ancestry diagnosed with young-onset non-autoimmune diabetes. Early diagnosis of WS is important for therapeutic approaches, especially since novel medications are becoming available. |
format | Article |
id | doaj-art-aa3130497f0348949749105a44c0266f |
institution | Kabale University |
issn | 2296-2360 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pediatrics |
spelling | doaj-art-aa3130497f0348949749105a44c0266f2025-01-29T06:46:11ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602025-01-011310.3389/fped.2025.15258461525846Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze populationInbal Halabi0Inbal Halabi1Yardena Tenenbaum-Rakover2Yardena Tenenbaum-Rakover3Lena Sagi-Dain4Lena Sagi-Dain5Lena Sagi-Dain6Ilana Koren7Ilana Koren8Ilana Koren9Pediatric Endocrine Unit, Carmel Medical Center, Haifa, IsraelClalit Health Services, Haifa, IsraelChildren’s Endocrinology Consulting Center, Clalit Health Services, Afula, IsraelThe Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelClalit Health Services, Haifa, IsraelThe Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelGenetic Institute, Carmel Medical Center, Haifa, IsraelPediatric Endocrine Unit, Carmel Medical Center, Haifa, IsraelClalit Health Services, Haifa, IsraelThe Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelContextWolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder caused by pathogenic variants in the WFS1 gene. It is characterized by central diabetes insipidus, juvenile-onset diabetes mellitus (DM), optic atrophy (OA), and deafness. The natural history of WS is variable, even within the same family and with the same variant.ObjectiveTo report the phenotypes of five patients of Druze origin, all carrying the same autosomal recessive pathogenic variant in the WFS1 gene.Patients & methodsFive patients belonging to three core families were enrolled. Clinical, biochemical, and genetic data were retrieved retrospectively from their medical files.ResultsAll five patients carried the same previously reported homozygous WFS1 pathogenic variant: c.2649del, p.Phe884fs. In all patients, the first presentation was DM at a mean age of 5.2 years (range 4–7), diagnosed initially as type 1 DM with negative anti-pancreatic autoantibodies, and all were treated with insulin by either pump or multiple injections. All five patients had OA that appeared at a mean age of 12.3 years (range 4–30). Three had hearing loss and neurological involvement, and none had diabetes insipidus. One patient was treated with a glucagon-like peptide 1 receptor agonist with a good response.ConclusionsThis is the first report of a founder pathogenic variant in the WFS1 gene in the Druze population in Israel. Our findings imply that molecular analysis is warranted in children presenting with DM and negative pancreatic antibodies. The identified variant should be considered for genetic testing in individuals of Druze ancestry diagnosed with young-onset non-autoimmune diabetes. Early diagnosis of WS is important for therapeutic approaches, especially since novel medications are becoming available.https://www.frontiersin.org/articles/10.3389/fped.2025.1525846/fullWolfram syndromediabetes mellitusoptic atrophyendoplasmic reticulumtype 1 diabetes mellitusdiabetic ketoacidosis |
spellingShingle | Inbal Halabi Inbal Halabi Yardena Tenenbaum-Rakover Yardena Tenenbaum-Rakover Lena Sagi-Dain Lena Sagi-Dain Lena Sagi-Dain Ilana Koren Ilana Koren Ilana Koren Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population Frontiers in Pediatrics Wolfram syndrome diabetes mellitus optic atrophy endoplasmic reticulum type 1 diabetes mellitus diabetic ketoacidosis |
title | Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population |
title_full | Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population |
title_fullStr | Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population |
title_full_unstemmed | Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population |
title_short | Identification of a pathogenic founder variant in the WFS1 gene that causes Wolfram syndrome in the Druze population |
title_sort | identification of a pathogenic founder variant in the wfs1 gene that causes wolfram syndrome in the druze population |
topic | Wolfram syndrome diabetes mellitus optic atrophy endoplasmic reticulum type 1 diabetes mellitus diabetic ketoacidosis |
url | https://www.frontiersin.org/articles/10.3389/fped.2025.1525846/full |
work_keys_str_mv | AT inbalhalabi identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT inbalhalabi identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT yardenatenenbaumrakover identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT yardenatenenbaumrakover identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT lenasagidain identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT lenasagidain identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT lenasagidain identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT ilanakoren identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT ilanakoren identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation AT ilanakoren identificationofapathogenicfoundervariantinthewfs1genethatcauseswolframsyndromeinthedruzepopulation |